SMWB•November 17, 2026 at 2:16 PM UTCSoftware & Services

Similarweb Q3 beat reinforces base case, but NRR still key

Read source article

What happened

Similarweb reported Q3 non-GAAP EPS of $0.10, beating the $0.08 consensus and more than doubling the $0.05 a year ago, with revenue also exceeding estimates. This beat aligns with the company's operational improvements noted in the deep value report, including steady customer growth and expanding large-customer contributions. However, the magnitude of the beat on an absolute basis remains small, and the critical watchpoint of net revenue retention (NRR) has not yet been disclosed in the brief news item. The report's base case projected revenue growth of 11-14% and FCF margin of 5-7%, so a beat suggests execution is tracking at least in line, if not slightly ahead. Investors will now look to the full earnings release and conference call for details on NRR, GenAI ARR, and any updated guidance to confirm that the beat is sustainable rather than a one-quarter anomaly.

Implication

The earnings beat reinforces that Similarweb's shift toward profitability and disciplined spending is delivering tangible results, even as growth has decelerated from its peak. However, the company remains valued at a high multiple of depressed earnings, so a single beat is unlikely to trigger a re-rating without confirmation of improving NRR and sustained double-digit growth. Investors should look for the full Q3 release to confirm that the beat was driven by recurring revenue acceleration rather than one-time items or cost timing. If NRR has stabilized above 100% and GenAI ARR shows meaningful progression, the base case scenario becomes more probable, supporting the $9 implied value. Conversely, if the beat is overshadowed by continued NRR weakness or deteriorating free cash flow, the bear case of $4.50 becomes more relevant, and trimming positions near $10 would be prudent.

Thesis delta

The thesis remains unchanged at its core: Similarweb is a potential buy at current levels if it can sustain low-to-mid teens growth with improving margins. The Q3 beat provides incremental confidence that management is executing on its profitable growth strategy, but it does not yet address the key risks of NRR decline and balance-sheet refinancing. We maintain our conviction at 3.5/5, with no change to our attractive entry of $5 or trim above $10, pending full details from the earnings call.

Confidence

Moderate